Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving¹³¹I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma

Abstract

Although we cannot exclude the possibility of some inhibition of (131) I-MIBG uptake by midazolam or dexmedetomidine, this case series suggests that continuous infusions of either agent can provide effective sedation to allow safe administration of (131) I-MIBG to young patients.